KMDA

Q: What is the price of Kamada (KMDA) today?

The current price of Kamada (KMDA) is $ 7.17, representing a 7.79% gain over the past year. The stock began the year trading around $ 7.06 and is currently priced at $ 7.17. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Kamada (KMDA) pay dividends?

In the last year, Kamada (KMDA) distributed dividends in the month of April, totaling $ 0.25. The Dividend Yield for the last 12 months is 3.48%.

Q: Is Kamada (KMDA) a good investment?

Kamada (KMDA) is currently trading at $ 7.17 with a P/E ratio of 20.77. This represents a 532% premium compared to its historical average P/E. Over the past year, the stock has gained 7.79 and paid $ 0.25 in dividends, resulting in a dividend yield of 3.48%. The total shareholder return over the same period was 7.79%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Kamada Ltd.

Price

$ 7.17

return (12m)

7.79%

p/e

20.77

p/bv

1.63

DIVIDEND YIELD

3.48%

KMDA price

Kamada

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KMDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-13.20%

3 months

-16.66%

1 year

7.79%

2 years

47.17%

5 years

29.59%

10 years

0.00%

Fundamentals KMDA

review the fundamentals of Kamada shares

P/E

20.77

Sector: -4.07 Industry: -4.07

P/S (PSR)

2.33

Sector: -4.20 Industry: -4.20

P/BV

1.63

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

3.48%

Sector: - Industry: -

ROA

5.32%

Sector: -65.81% Industry: -65.81%

ROE

7.85%

Sector: -65.98% Industry: -65.98%

ROIC

7.88%

Sector: -2,913.96% Industry: -2,913.96%

NET MARGIN

11.21%

Sector: -40.61% Industry: -40.61%

GROSS MARGIN

41.16%

Sector: 36.34% Industry: 36.34%

OPERATING MARGIN

13.98%

Sector: -39.56% Industry: -39.56%

EV/EBITDA

11.06

Sector: -4.19 Industry: -4.19

EV/EBIT

18.31

Sector: -4.27 Industry: -4.27

PRICE-TO-ASSETS

1.10

Sector: 1.46 Industry: 1.46

BVPS

4.40

Sector: 1.87 Industry: 1.87

EPS

0.35

Sector: -2.18 Industry: -2.18

EQUITY-TO-ASSETS RATIO

0.68

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.32

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

11.88%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Kamada ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 7.17

Fair Value

$ 5.89

Upside Return potential.

-17.90%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals KMDA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.50	6.87	25.92%	2.25%	$ 557.54 B	21.83%
PFE	19.79	1.64	8.29%	6.61%	$ 148.19 B	11.83%
ABBV	110.65	-60.83	-54.98%	2.97%	$ 402.20 B	5.79%
NVO	10.06	6.08	60.40%	4.34%	$ 190.87 B	37.15%
MRK	33.42	6.50	19.45%	2.75%	$ 298.59 B	13.59%
AZN	27.73	6.08	21.93%	1.72%	$ 288.04 B	17.19%
GILD	17.41	6.85	39.33%	2.47%	$ 160.42 B	30.99%
BMY	16.04	5.81	36.19%	4.37%	$ 116.72 B	15.01%
ZTS	12.68	10.37	81.75%	2.59%	$ 33.52 B	27.79%
REGN	14.94	2.10	14.08%	0.57%	$ 66.09 B	29.65%
HALO	24.20	38.43	158.82%	0.00%	$ 8.44 B	23.13%
AMGN	24.20	20.54	84.87%	2.80%	$ 188.77 B	20.96%
MCK	19.85	-113.34	-570.98%	0.41%	$ 94.53 B	1.18%
HRMY	12.82	2.05	16.00%	0.00%	$ 1.87 B	16.20%
VRTX	26.16	5.86	22.41%	0.00%	$ 113.49 B	35.51%
CAH	31.09	-18.09	-58.20%	0.99%	$ 48.34 B	0.62%
ADMA	11.37	4.82	42.37%	0.00%	$ 1.88 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KMDA Historical Dividends

current DY: 3.48%

5-year average DY: 2.90%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/20/2026	04/06/2026	0,24960000
Dividends	03/14/2025	04/07/2025	0,20000000

ABOUT Kamada

Kamada Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

2013

Time since IPO - 13 years

408

Employees

Kamada Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $423.03 Millions, with shareholders equity totaling $259.39 Millions.

The company employs approximately 408 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kamada Ltd. reported $181.68 Millions in revenue, generating net income of $20.37 Millions.

Key financial metrics include a P/E ratio of 20.77, a price-to-book (P/B) ratio of 1.63, and a trailing twelve-month dividend yield of 3.48%.

The company trades under the ticker KMDA.

Market cap

$ 423.03 Millions

Net worth

$ 259.39 Millions

$ 259,390,000.00

Assets

$ 383.02 Millions

$ 383,020,000.00

Total Shares Outstanding

59.00 Millions

59,000,000

Average Daily Trading Volume

$ 51.72 Thousand

$ 51,718.00

Sector

Health Care

Industry

Biotechnology

KMDA

KMDA revenue and profits

Financial Results KMDA

DRAG THE FRAME TO SEE MORE DATA

KMDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.66 9,24% (12M)

P/E

19.85

0.41%

ROE

-570.98%

P/BV

-113.34

CAH - Cardinal Health

$ 205.71 34,48% (12M)

P/E

31.09

0.99%

ROE

-58.20%

P/BV

-18.09

JNJ - Johnson & Johnson

$ 232.77 55,23% (12M)

P/E

26.50

2.25%

ROE

25.92%

P/BV

6.87

MRK - Merck & Co.

$ 120.79 58,48% (12M)

P/E

33.42

2.75%

ROE

19.45%

P/BV

6.50

AZN - AstraZeneca

$ 185.95 29,58% (12M)

P/E

27.73

1.72%

ROE

21.93%

P/BV

6.08

ABBV - AbbVie

$ 227.23 23,51% (12M)

P/E

110.65

2.97%

ROE

-54.98%

P/BV

-60.83

NVO - Novo Nordisk

$ 42.96 --39,65% (12M)

P/E

10.06

4.34%

ROE

60.40%

P/BV

6.08

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.66 9,24% (12 M)

P/L

19.85

0.41%

ROE

-570.98%

P/VP

-113.34

CAH - Cardinal Health

$ 205.71 34,48% (12 M)

P/L

31.09

0.99%

ROE

-58.20%

P/VP

-18.09

JNJ - Johnson & Johnson

$ 232.77 55,23% (12 M)

P/L

26.50

2.25%

ROE

25.92%

P/VP

6.87

MRK - Merck & Co.

$ 120.79 58,48% (12 M)

P/L

33.42

2.75%

ROE

19.45%

P/VP

6.50

AZN - AstraZeneca

$ 185.95 29,58% (12 M)

P/L

27.73

1.72%

ROE

21.93%

P/VP

6.08

ABBV - AbbVie

$ 227.23 23,51% (12 M)

P/L

110.65

2.97%

ROE

-54.98%

P/VP

-60.83

NVO - Novo Nordisk

$ 42.96 --39,65% (12 M)

P/L

10.06

4.34%

ROE

60.40%

P/VP

6.08

Frequently Asked Questions

What is the price of Kamada (KMDA) today?

The current price of Kamada (KMDA) is $ 7.17, representing a 7.79% gain over the past year. The stock began the year trading around $ 7.06 and is currently priced at $ 7.17. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kamada (KMDA) pay dividends?

In the last year, Kamada (KMDA) distributed dividends in the month of April, totaling $ 0.25. The Dividend Yield for the last 12 months is 3.48%.

Is Kamada (KMDA) a good investment?

Kamada (KMDA) is currently trading at $ 7.17 with a P/E ratio of 20.77. This represents a 532% premium compared to its historical average P/E. Over the past year, the stock has gained 7.79 and paid $ 0.25 in dividends, resulting in a dividend yield of 3.48%. The total shareholder return over the same period was 7.79%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kamada (KMDA) stock?

You can buy Kamada (KMDA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KMDA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kamada (KMDA) yield today?

Over the past month, Kamada (KMDA) has returned -13.20% — 7.79% over the past year, and 29.59% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.25 per share in dividends, resulting in a dividend yield of 3.48%.

If you were to purchase 100 shares of Kamada (KMDA) today at the current price of $ 7.17 your total investment would be $ 717.00.

Based on historical performance, the investment would have grown to approximately:

$ 772.85 after 1 year
$ 929.16 after 5 years
$ 717.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KMDA

Kamada Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KMDA

review the fundamentals of Kamada shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 3.48%

5-year average DY: 2.90%

type

Ex - Dividend Date

payment date

value

ABOUT Kamada

Kamada Ltd.

United States

36 years

2013

408

PROFIT X PRICE KMDA

Financial Results KMDA

KMDA cash flow

Asset, Revenue and Profit Growth - KMDA

KMDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions